Max Healthcare Institute Limited has informed the Exchange regarding a press release dated November 14, 2025, titled "Max Healthcare Q2 revenue soars to ₹ 2,692 Cr, registering growth of +21% YoY; Network Operating EBITDA grows to ₹ 694 Cr, +23% YoY; PAT grows by +59% YoY to ₹ 554 Cr".
MAXHEALTH · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Max Healthcare reported Q2 FY26 revenue of ₹2,692 Cr, up 21% year-on-year, driven by strong performance across its hospital network. Network Operating EBITDA grew 23% YoY to ₹694 Cr, outpacing revenue growth and indicating improved operating leverage. Profit after tax (PAT) surged 59% YoY to ₹554 Cr, reflecting strong bottom-line growth on the back of higher revenues and likely operational efficiencies. The results highlight sustained momentum in the hospital business with broad-based growth across metrics.
This is a clearly positive earnings update — revenue growth above 20%, double-digit EBITDA expansion, and near 60% PAT growth signal strong operational performance and are likely to be viewed favorably by the market, potentially supporting the stock price.